SOLACI Symposium at the EuroPCR 2025 Congress

The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field worldwide. In this regard, the Society will participate in the EuroPCR 2025 Congress (to be held in Paris, France, from May 20 to 23) with a joint session on “Clinical and technical factors for decision-making in the treatment of left main coronary artery disease.”

The symposium will feature experts from both Latin America and Europe, and its main highlight will be the presentation of the “SOLACI / SIAC Guidelines for Left Main Coronary Artery Revascularization”, the result of extensive work carried out between both scientific societies. The SOLACI / SIAC Guidelines will be simultaneously published in a prestigious international PubMed-indexed journal at the time of the session.

May 22, 2025 | 09:45 am to 10:45 am (UTC +2) | Room 252B

Below are the session details. We look forward to seeing you all in Paris!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....